SCHEMBL25911892

SCHEMBL25911892

Cc1n(C)c2ccccc2[n+]1N

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GPR3 P46089 1/20 0.38
ERAP1 Q9NZ08 1/20 0.38
KDM4E B2RXH2 6/20 0.37
ALDH1A1 P00352 3/20 0.37
MAPT P10636 2/20 0.37
L3MBTL1 Q9Y468 2/20 0.37
LCK P06239 1/20 0.36
RAB9A P51151 2/20 0.36
LMNA P02545 1/20 0.36
HTT P42858 1/20 0.36
PTPN1 P18031 1/20 0.34
APOBEC3A P31941 1/20 0.33
APOBEC3G Q9HC16 1/20 0.33
ADORA1 P30542 1/20 0.33
ALKBH5 Q6P6C2 1/20 0.33
FTO Q9C0B1 1/20 0.33
ALOX15 P16050 2/20 0.33
NPC1 O15118 1/20 0.33
TP53 P04637 1/20 0.33
GAA P10253 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1049324 0.77 ERAP1 (0.50) GPR3ERAP1KDM4EALDH1A1MAPT
Water SCHEMBL21823213 0.75 ERAP1 (0.49) GPR3ERAP1KDM4EALDH1A1MAPT
SCHEMBL474643 0.75 KDM4E (0.41) GPR3ERAP1KDM4EALDH1A1MAPT
Iodide SCHEMBL9134481 0.75 PTPN1 (0.50) GPR3ERAP1KDM4EALDH1A1MAPT
SCHEMBL25911921 0.75 KDM4E (0.41) KDM4EALDH1A1L3MBTL1LCKHTT
SCHEMBL26434159 0.74 ERAP1 (0.39) GPR3ERAP1KDM4EALDH1A1MAPT
SCHEMBL25911898 0.73 ATM (0.38) KDM4EALDH1A1MAPTRAB9ALMNA
SCHEMBL25911896 0.73 NFATC1 (0.37) MAPTLCKRAB9ANPC1TP53
SCHEMBL3457693 0.72 KDM4E (0.49) GPR3ERAP1KDM4EALDH1A1MAPT
SCHEMBL25911951 0.72 LCK (0.41) LCKPTPN1ALKBH5FTO

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11716898-B2 Organic electroluminescent materials and devices UNIVERSAL DISPLAY CORPORATION (US) 2023-08-01 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11716898-B2 Organic electroluminescent materials and devices OCIAD2, OCIAD1, JUND GPR3 2942/4885ERAP1 3246/4885KDM4E 2637/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.